首页> 外文期刊>BMC Emergency Medicine >Prognostic value of neutrophil- lymphocyte count ratio (NLCR) among adult ICU patients in comparison to APACHE II score and conventional inflammatory markers: a multi center retrospective cohort study
【24h】

Prognostic value of neutrophil- lymphocyte count ratio (NLCR) among adult ICU patients in comparison to APACHE II score and conventional inflammatory markers: a multi center retrospective cohort study

机译:成人ICU患者中嗜中性粒细胞淋巴细胞计数比率(NLCR)的预后值与Apache II评分和常规炎症标记相比:多中心回顾队列研究

获取原文
           

摘要

Neutrophil-lymphocyte count ratio (NLCR) has been reported as better indicator of bacteremia than procalcitonin (PCT), and more precise predictor of mortality than C-reactive protein (CRP) under various medical conditions. However, large controversy remains upon this topic. To address the discrepancy, our group has compared the efficiency of NLCR with conventional inflammatory markers in predicting the prognosis of critical illness. We performed a multi-center retrospective cohort study involving 536 ICU patients with outcomes of survival, 28- and 7-day mortality. NLCR was compared with conventional inflammatory markers such as PCT, CRP, serum lactate (LAC), white blood cell, neutrophil and severity score APACHE II (Acute Physiology and Chronic Health Evaluation II) to evaluate the potential outcomes of critical illness. Then, receiver operating characteristics (ROC) curves were constructed to assess and compare each marker’s sensitivity and specificity respectively. NLCR values were not different between survival and mortality groups. Meanwhile, remarkable differences were observed upon APACHE II score, CRP, PCT and LAC levels between survival and death groups. ROC analysis revealed that NLCR was not competent to predict prognosis of critical illness. The AUROCs of conventional markers such as CRP, PCT, LAC and APACHE II score were more effective in predicting 28- and 7-day mortality. NLCR is less reliable than conventional markers CRP, PCT, LAC and APACHE II score in assessing severity and in predicting outcomes of critical illness.
机译:据报道,中性粒细胞淋巴细胞计数比(NLCR)作为比ProCalcitonin(PCT)更好的菌血症指标,以及在各种医疗条件下比C反应蛋白(CRP)更精确的死亡率。但是,这个话题仍然存在大争议。为了解决差异,我们的小组将NLCR的效率与常规炎症标志物进行了比较预测危急疾病的预后。我们进行了一个多中心回顾性队列研究,涉及536名ICU患者,其患者的生存结果,28天和7天死亡率。将NLCR与常规炎症标记进行比较,例如PCT,CRP,血清乳酸(LAC),白细胞,中性粒细胞和严重程度评分Apache II(急性生理学和慢性健康评估II),以评估危重疾病的潜在结果。然后,构建接收器操作特性(ROC)曲线以分别评估和比较每个标记的灵敏度和特异性。生存和死亡群之间的NLCR值与不同。同时,在存活和死亡团之间的Apache II得分,CRP,PCT和LAC水平上观察到显着差异。 ROC分析表明,NLCR不称职,以预测危重疾病的预后。常规标记的常规标志物如CRP,PCT,LAC和Apache II评分在预测28和7天死亡率方面更有效。 NLCR比常规标志物CRP,PCT,LAC和Apache II得分少于评估严重程度以及预测危重疾病的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号